Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Previously submitted to: Journal of Medical Internet Research (no longer under consideration since Sep 03, 2021)

Date Submitted: Jun 11, 2021

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

The Potential of Digital Symptom-based Screening to Reduce the Transmission of SARS-CoV-2: a Modelling Study

  • Jan Multmeier; 
  • Maryam Montazeri; 
  • Nicola Vona; 
  • François Bergey; 
  • Alicia Mehl; 
  • Andreas Gilsdorf

ABSTRACT

Background:

Early efforts to control the COVID-19 pandemic have been focused on Non-Pharmaceutical Interventions (NPIs) in the absence of effective treatments or sufficient vaccine supply. While retrospective analyses and modeling studies confirmed that severe restrictions of social contacts, i.e., lockdowns, are most effective in reducing transmission of SARS-CoV-2, they incur large economic costs and mental health risks. Earlier detection of cases has also been proposed as an effective method of control, but studies have so far only considered enhanced laboratory testing. Digital applications have been developed which aim to identify possible cases of COVID-19 based on reported symptoms and risk factors.

Objective:

The aim of this study is to explore the effects of digital screening applications for COVID-19 on the transmission of SARS-CoV-2.

Methods:

Using an established epidemiological Susceptible-Exposed-Infectious-Recovered (SEIR) model for infectious disease transmission, we simulate the transmission of SARS-CoV-2 in Germany, the UK, and the USA for 366 days after the virus was introduced in the population. We study 4 scenarios: 1) no interventions (base case), 2) symptom-based self-isolation after consulting healthcare providers, 3) self-isolation using digital screening applications, and 4) severe social contact limitations (lockdown). We included sensitivity analyses for different ratios of infectiousness of pre-symptomatic cases compared to symptomatic cases, and different rates of adoption of digital screening tools.

Results:

Without any intervention, 74% of the German population would be infected with SARS-CoV-2 within the simulation period (UK: 76%, USA: 77%). Self-isolation of symptomatic cases would already slow the spread of the virus significantly and lead to only 18% of the German population being infected (UK: 17%, USA: 17%). Using a digital application could further reduce the infected population to 10% (UK: 9%, USA: 9%), compared to 3% under lockdown conditions. While the effectiveness of digital screening applications varies with the adoption rate, even a low adoption rate could significantly reduce transmission. In the case that pre-symptomatic cases are less infectious than symptomatic cases, the overall proportion of infected individuals in the population decreases, and the effectiveness of different interventions converges.

Conclusions:

Digital symptom-based screening tools can substantially impact the transmission of SARS-CoV-2 and might be a viable element in strategies to control COVID-19 through NPIs.


 Citation

Please cite as:

Multmeier J, Montazeri M, Vona N, Bergey F, Mehl A, Gilsdorf A

The Potential of Digital Symptom-based Screening to Reduce the Transmission of SARS-CoV-2: a Modelling Study

JMIR Preprints. 11/06/2021:31139

DOI: 10.2196/preprints.31139

URL: https://preprints.jmir.org/preprint/31139

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.